Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells

C. Brambilla, M. Folini, P. Gandellini, L. Daprai, M. G. Daidone, N. Zaffaroni

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The expression of telomerase in human cells is strictly controlled by multiple mechanisms including transcription and alternative splicing of telomerase reverse transcriptase (hTERT). In this study, we demonstrated the possibility of modulating the hTERT splicing pattern in DU145 human prostate carcinoma cells through the use of 2′-O-methyl-RNA phosphorothioate oligonucleotides targeting the splicing site located between intron 5 and exon 6 in the hTERT pre-mRNA. An 18-h oligonucleotide exposure induced a decrease in the full-length hTERT transcript and a concomitant increase in the alternatively spliced transcripts, which resulted in significant inhibition of telomerase catalytic activity. Moreover, exposure to the R7 oligomer (which induced the most pronounced modulation of the hTERT splicing pattern and the greatest telomerase inhibition) caused a marked reduction in DU145 cell growth and the induction of apoptosis starting 2 days after treatment. Such data support the concept that down-regulation of hTERT expression can cause short-term effects on tumour cell growth, which are telomere-shortening independent.

Original languageEnglish
Pages (from-to)1764-1774
Number of pages11
JournalCellular and Molecular Life Sciences
Volume61
Issue number14
Publication statusPublished - Jul 2004

Fingerprint

Telomerase
Alternative Splicing
Cell growth
Oligomers
Prostatic Neoplasms
Cells
Modulation
Growth
Phosphorothioate Oligonucleotides
Telomere Shortening
RNA Precursors
Transcription
Oligonucleotides
Introns
Tumors
Prostate
Exons
Catalyst activity
Down-Regulation
RNA

Keywords

  • 2′-O-methyl phosphorothioate oligoribonucleotide
  • Alternative splicing
  • Apoptosis
  • DU145 prostate cancer cell line
  • hTERT catalytic subunit

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Cell Biology

Cite this

@article{bab6387e4689400f97c0701cee056ddf,
title = "Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells",
abstract = "The expression of telomerase in human cells is strictly controlled by multiple mechanisms including transcription and alternative splicing of telomerase reverse transcriptase (hTERT). In this study, we demonstrated the possibility of modulating the hTERT splicing pattern in DU145 human prostate carcinoma cells through the use of 2′-O-methyl-RNA phosphorothioate oligonucleotides targeting the splicing site located between intron 5 and exon 6 in the hTERT pre-mRNA. An 18-h oligonucleotide exposure induced a decrease in the full-length hTERT transcript and a concomitant increase in the alternatively spliced transcripts, which resulted in significant inhibition of telomerase catalytic activity. Moreover, exposure to the R7 oligomer (which induced the most pronounced modulation of the hTERT splicing pattern and the greatest telomerase inhibition) caused a marked reduction in DU145 cell growth and the induction of apoptosis starting 2 days after treatment. Such data support the concept that down-regulation of hTERT expression can cause short-term effects on tumour cell growth, which are telomere-shortening independent.",
keywords = "2′-O-methyl phosphorothioate oligoribonucleotide, Alternative splicing, Apoptosis, DU145 prostate cancer cell line, hTERT catalytic subunit",
author = "C. Brambilla and M. Folini and P. Gandellini and L. Daprai and Daidone, {M. G.} and N. Zaffaroni",
year = "2004",
month = "7",
language = "English",
volume = "61",
pages = "1764--1774",
journal = "Cellular and Molecular Life Sciences",
issn = "1420-682X",
publisher = "Birkhauser Verlag Basel",
number = "14",

}

TY - JOUR

T1 - Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells

AU - Brambilla, C.

AU - Folini, M.

AU - Gandellini, P.

AU - Daprai, L.

AU - Daidone, M. G.

AU - Zaffaroni, N.

PY - 2004/7

Y1 - 2004/7

N2 - The expression of telomerase in human cells is strictly controlled by multiple mechanisms including transcription and alternative splicing of telomerase reverse transcriptase (hTERT). In this study, we demonstrated the possibility of modulating the hTERT splicing pattern in DU145 human prostate carcinoma cells through the use of 2′-O-methyl-RNA phosphorothioate oligonucleotides targeting the splicing site located between intron 5 and exon 6 in the hTERT pre-mRNA. An 18-h oligonucleotide exposure induced a decrease in the full-length hTERT transcript and a concomitant increase in the alternatively spliced transcripts, which resulted in significant inhibition of telomerase catalytic activity. Moreover, exposure to the R7 oligomer (which induced the most pronounced modulation of the hTERT splicing pattern and the greatest telomerase inhibition) caused a marked reduction in DU145 cell growth and the induction of apoptosis starting 2 days after treatment. Such data support the concept that down-regulation of hTERT expression can cause short-term effects on tumour cell growth, which are telomere-shortening independent.

AB - The expression of telomerase in human cells is strictly controlled by multiple mechanisms including transcription and alternative splicing of telomerase reverse transcriptase (hTERT). In this study, we demonstrated the possibility of modulating the hTERT splicing pattern in DU145 human prostate carcinoma cells through the use of 2′-O-methyl-RNA phosphorothioate oligonucleotides targeting the splicing site located between intron 5 and exon 6 in the hTERT pre-mRNA. An 18-h oligonucleotide exposure induced a decrease in the full-length hTERT transcript and a concomitant increase in the alternatively spliced transcripts, which resulted in significant inhibition of telomerase catalytic activity. Moreover, exposure to the R7 oligomer (which induced the most pronounced modulation of the hTERT splicing pattern and the greatest telomerase inhibition) caused a marked reduction in DU145 cell growth and the induction of apoptosis starting 2 days after treatment. Such data support the concept that down-regulation of hTERT expression can cause short-term effects on tumour cell growth, which are telomere-shortening independent.

KW - 2′-O-methyl phosphorothioate oligoribonucleotide

KW - Alternative splicing

KW - Apoptosis

KW - DU145 prostate cancer cell line

KW - hTERT catalytic subunit

UR - http://www.scopus.com/inward/record.url?scp=3843059093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3843059093&partnerID=8YFLogxK

M3 - Article

C2 - 15241552

AN - SCOPUS:3843059093

VL - 61

SP - 1764

EP - 1774

JO - Cellular and Molecular Life Sciences

JF - Cellular and Molecular Life Sciences

SN - 1420-682X

IS - 14

ER -